Abstract
Identifying affordable drug therapy options for individuals who lack prescription drug insurance is a problem frequently encountered by prescribers. Medication samples and manufacturer-sponsored assistance programs represent sources often used to address affordability issues. However, these sources have the potential to introduce health disparities through various mechanisms, including reduced access to the drug of choice, consistencies with access, and drug regimen complexities that adversely affect adherence. Prescribers should consider all sources of affordable medications and openly discuss treatment options and the anticipated outcomes of each with patients to ensure the prescribing of agents that optimize outcomes while balancing patient affordability.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 152-160 |
| Number of pages | 9 |
| Journal | Journal of health care for the poor and underserved |
| Volume | 15 |
| Issue number | 2 |
| State | Published - May 2004 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being -
SDG 10 Reduced Inequalities
Keywords
- Drug therapy
- Health disparities
- Prescribing
- Underinsured
- Uninsured
Fingerprint
Dive into the research topics of 'The limitation of good intentions: Prescribing medications for the uninsured'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS